Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Throly system predicts thromboprophylaxis in lymphoma patients

Leukemia and Lymphoma 2018, Dubrovnik, Croatia

Publish date:: October 11, 2018

Key clinical point: The updated ThroLy scoring system had a high negative predictive value for thromboembolic events in lymphoma patients.

Major finding: The updated ThroLy had a positive predictive value of 22%-25%, a negative predictive value of 96%, sensitivity of 56%-57%, and specificity of 85%-87%.

Study details: The scoring system was validated on 1,723 lymphoma patients treated at eight institutions worldwide.

Disclosures: Dr. Antic reported having no conflicts of interest.

Read the article here.

Citation:

Leukemia and Lymphoma 2018, Dubrovnik, Croatia

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Aggressive Lymphomas

Study Halted; ‘Hyperprogression’ Seen With Nivolumab for R/R PTCL,

CAR T-Cell Therapy Found Safe, Effective For HIV-Associated Lymphoma,

Bispecific CAR T-cell Therapy Yields Complete Responses in Relapsed/Refractory non-Hodgkin Lymphomas,

5F9 Plus Rituximab Take a Bite Out of Drug-Resistant NHL,

‘Encouraging’ Responses Seen With Durvalumab Plus R-CHOP in DLBCL,